bell
The current prices are delayed by 15 mins, login to check live prices.
Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd

(NATHBIOGEN)

₹189.281.99%

as on 04:01PM, 04 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Nath Bio-Genes (India) Ltd Performance

  • Day's Low

    Day's High

    ₹187.21
    ₹196.5
  • 52 Week's Low

    52 Week's High

    ₹167.15
    ₹264.31
1 Month Return-7.91 %
3 Month Return-14.02 %
1 Year Return+ 3.06 %
Previous Close₹193.13
Open₹196.50
Volume13.67K
Upper Circuit-
Lower Circuit-
Market Cap₹367.02Cr

Nath Bio-Genes (India) Ltd Key Statistics

P/E Ratio8.81
PEG Ratio4.45
Market Cap₹367.02 Cr
P/B Ratio0.54
EPS20.85
Dividend Yield1.15
SectorMiscellaneous
ROE6.79

Nath Bio-Genes (India) Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹367.02 Cr-8.31%0.58₹39 Cr₹332 Cr
NA₹526.26 Cr219.86%0.50NANA
NA₹12.91 Cr197%0.50NANA
NA₹520.67 Cr142.91%0.51NANA
NA₹2,202.97 Cr1.01%0.00₹66 Cr₹1,067 Cr

Nath Bio-Genes (India) Ltd Mutual Fund Holdings

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Share Price: ₹189.28 per share as on 04 Nov, 2024 04:01 PM
Market Capitalisation: ₹367.02Cr as of today
Revenue: ₹32.19Cr as on September 2024 (Q3 24)
Net Profit: ₹1.11Cr as on September 2024 (Q3 24)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
Headquarters
IndustryMiscellaneous
E-voting on sharesClick here to vote

Key events for Nath Bio-Genes (India) Ltd

  • Nath Bio-Genes Reports Strong Sales Growth - 24 Oct, 2024

    Nath Bio-Genes announced standalone net sales of Rs 32.19 crore for September 2024, a 42.65% increase YoY. Net profit rose 42.05%, while EPS improved to Rs 1.46.

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 49.81% to 49.85% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Godrej Agrovet Ltd has given 49.7% return, outperforming this stock by 46.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Kaveri Seed Company Ltd has given 75.0% return, outperforming this stock by 110.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 33.35 Cr → 1.11 Cr (in ₹), with an average decrease of 96.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, NATHBIOGEN stock has moved down by -35.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 244.01 Cr → 32.27 Cr (in ₹), with an average decrease of 86.8% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.21% to 0.18% in Sep 2024 quarter

Nath Bio-Genes (India) Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹22.57Cr (-)₹31.74Cr (↑40.63%)₹43.04Cr (↑35.60%)₹243.88Cr (↑466.64%)₹32.19Cr (↓86.80%)
Net Income₹1.50Cr (-)₹3.82Cr (↑154.67%)₹2.62Cr (↓31.41%)₹33.35Cr (↑1,172.90%)₹1.11Cr (↓96.67%)
Net Profit Margin6.65% (-)12.04% (↑81.05%)6.09% (↓49.42%)13.67% (↑124.47%)3.45% (↓74.76%)
Value in ₹ crore
Details2021202220232024
Total Assets₹789.52Cr (-)₹739.54Cr (↓6.33%)₹792.97Cr (↑7.22%)₹877.08Cr (↑10.61%)
Total Liabilities₹176.25Cr (-)₹197.57Cr (↑12.10%)₹219.62Cr (↑11.16%)₹266.43Cr (↑21.31%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹9.48Cr (-)₹1.11Cr (↓88.29%)₹17.05Cr (↑1,436.04%)₹38.37Cr (↑125.04%)₹74.72Cr (↑94.74%)
0

Nath Bio-Genes (India) Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
45.6%
0.00
Foreign Institutions
0.18%
-14.10
Mutual Funds
4.37%
0.00
Retail Investors
49.85%
0.07
Others
0%
-55.71

Nath Bio-Genes (India) Ltd Key Indicators

Details20202021202220232024
Return On Equity %9.489.514.126.316.79
Details20232024
Return On Assets %4.424.52
Details202220232024
Book Value Per Share (₹)285.16301.61320.94
Details202220232024
Earning Per Share (₹)-35.4618.4220.85

Nath Bio-Genes (India) Ltd Valuation

Nath Bio-Genes (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (8.81x)

November 1, 2024

Industry (43.74x)

November 1, 2024

Highest (11.85x)

August 4, 2023

LowHigh

Nath Bio-Genes (India) Ltd Earnings and Dividends

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit fell -26.49% since last year same period to ₹1.11Cr in the Q2 2024-2025. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -96.67% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Nath Bio-Genes (India) Ltd Dividends May,2024

    In the quarter ending March 2024, Nath Bio-Genes (India) Ltd has declared dividend of ₹2 - translating a dividend yield of 1.06%.

    Read More about Dividends

Nath Bio-Genes (India) Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Nath Bio-Genes (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Nath Bio-Genes (India) Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Nath Bio-Genes (India) Ltd shares.

Nath Bio-Genes (India) Ltd (NATHBIOGEN) share price today is ₹189.28

Nath Bio-Genes (India) Ltd is listed on NSE

Nath Bio-Genes (India) Ltd is listed on BSE

  • Today’s highest price of Nath Bio-Genes (India) Ltd is ₹196.5.
  • Today’s lowest price of Nath Bio-Genes (India) Ltd is ₹187.21.

PE Ratio of Nath Bio-Genes (India) Ltd is 8.81

PE ratio = Nath Bio-Genes (India) Ltd Market price per share / Nath Bio-Genes (India) Ltd Earnings per share

Today’s traded volume of Nath Bio-Genes (India) Ltd(NATHBIOGEN) is 13.67K.

Today’s market capitalisation of Nath Bio-Genes (India) Ltd(NATHBIOGEN) is ₹367.02Cr.

Nath Bio-Genes (India) Ltd(NATHBIOGENPrice
52 Week High
₹264.31
52 Week Low
₹167.15

Nath Bio-Genes (India) Ltd(NATHBIOGEN) share price is ₹189.28. It is down -28.39% from its 52 Week High price of ₹264.31

Nath Bio-Genes (India) Ltd(NATHBIOGEN) share price is ₹189.28. It is up 13.24% from its 52 Week Low price of ₹167.15

Nath Bio-Genes (India) Ltd(NATHBIOGENReturns
1 Day Returns
-3.85%
1 Month Returns
-7.91%
3 Month Returns
-14.02%
1 Year Returns
3.06%